275.00p+0.00 (+0.00 %)01 Dec 2020, 14:46
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Faron Pharmaceuticals Oy Market & Company News

23.11.2020 07:00 Bexmarilimab (Clevegen) development updateRNS
20.11.2020 07:00 Issue of EquityRNS
16.10.2020 10:35 First Results from WHO Solidarity TrialRNS
14.10.2020 13:15 Grant of optionsRNS
30.09.2020 08:45 Holding(s) in CompanyRNS
24.09.2020 06:15 Exercise of optionsRNS
24.09.2020 06:00 Half-year ReportRNS
18.09.2020 06:00 MATINS trial data presented at ESMORNS
27.08.2020 06:00 Notice of Half-Year ReportRNS
18.08.2020 06:00 Traumakine UpdateRNS
17.08.2020 15:41 Second Price Monitoring ExtnRNS
17.08.2020 15:36 Price Monitoring ExtensionRNS
27.07.2020 06:00 Change of AdviserRNS
20.07.2020 15:41 Second Price Monitoring ExtnRNS
20.07.2020 15:35 Price Monitoring ExtensionRNS
08.07.2020 14:00 Managers’ transactionsRNS
16.06.2020 06:01 Faron hosts virtual R&D Day todayRNS
16.06.2020 06:00 Faron update on pipeline progress ahead of R&D DayRNS
15.06.2020 06:00 Faron receives EUR 2.1 million funding from BFRNS
11.06.2020 06:00 Faron selected for EUR2.5 million grant from EICRNS
01.06.2020 06:00 MATINS UpdateRNS
28.05.2020 06:00 Faron announces R&D Day to be held in JuneRNS
20.05.2020 06:00 Publication in Intensive Care MedicineRNS
18.05.2020 15:00 Results of the Annual General MeetingRNS
13.05.2020 12:00 Exercise of optionsRNS
12.05.2020 17:00 Managers’ transactionsRNS
11.05.2020 09:00 Faron receives grant from Business FinlandRNS
05.05.2020 06:00 Clevegen manufacturing agreementRNS
29.04.2020 12:15 Holding(s) in CompanyRNS
27.04.2020 13:45 Holding(s) in CompanyRNS
27.04.2020 06:00 Traumakine to be a part of WHO’s Solidarity trialRNS
23.04.2020 12:00 Update on results of Placing and issue of equityRNS
22.04.2020 06:00 Result of placing and issue priceRNS
21.04.2020 15:45 Proposed PlacingRNS
15.04.2020 10:06 Second Price Monitoring ExtnRNS
15.04.2020 10:00 Price Monitoring ExtensionRNS
14.04.2020 06:00 Notice of Annual General MeetingRNS
03.04.2020 13:45 AGM to be postponedRNS
01.04.2020 06:00 REMAP-CAP to study IFN beta-1a effect in COVID-19RNS
30.03.2020 06:00 Part 1 of the MATINS Phase I/II Study CompletedRNS
26.03.2020 10:00 Correction to Faron´s Annual Report 2019RNS
25.03.2020 07:28 Faron´s Annual Report 2019 publishedRNS
20.03.2020 11:30 Notice of Annual General MeetingRNS
20.03.2020 07:00 Final Results for the year ended December 31, 2019RNS
19.03.2020 16:41 Second Price Monitoring ExtnRNS
19.03.2020 16:36 Price Monitoring ExtensionRNS
12.03.2020 16:44 Second Price Monitoring ExtnRNS
12.03.2020 16:38 Price Monitoring ExtensionRNS
09.03.2020 07:00 FDA accepts protocol for new Traumakine trialRNS
05.03.2020 07:00 MATINS updateRNS
02.03.2020 07:00 Faron to acquire AOC3 antagonist platformRNS
26.02.2020 07:05 Price Monitoring ExtensionRNS
26.02.2020 07:01 Second Price Monitoring ExtnRNS
26.02.2020 07:00 Price Monitoring ExtensionRNS
25.02.2020 14:05 Second Price Monitoring ExtnRNS
25.02.2020 14:00 Price Monitoring ExtensionRNS
25.02.2020 11:00 Price Monitoring ExtensionRNS
24.02.2020 16:41 Second Price Monitoring ExtnRNS
24.02.2020 16:35 Price Monitoring ExtensionRNS
18.02.2020 11:06 Second Price Monitoring ExtnRNS
18.02.2020 11:00 Price Monitoring ExtensionRNS
18.02.2020 09:05 Second Price Monitoring ExtnRNS
18.02.2020 09:00 Price Monitoring ExtensionRNS
06.02.2020 07:00 Traumakine updateRNS
27.01.2020 07:00 Ovarian cancer selected as 2nd MATINS trial cohortRNS
13.01.2020 07:00 DMC approves colorectal cancer cohort expansionRNS
30.12.2019 09:30 Update on Traumakine drug substance manufacturingRNS
12.12.2019 14:00 Price Monitoring ExtensionRNS
11.12.2019 07:00 Matins Trial UpdateRNS
02.12.2019 14:06 Second Price Monitoring ExtnRNS
02.12.2019 14:00 Price Monitoring ExtensionRNS
29.11.2019 14:05 Second Price Monitoring ExtnRNS
29.11.2019 14:00 Price Monitoring ExtensionRNS
29.11.2019 07:31 LIQUIDITY PROVIDING AGREEMENTRNS
29.11.2019 07:30 Company Description & information on cash positionRNS
28.11.2019 09:05 Second Price Monitoring ExtnRNS
28.11.2019 09:00 Price Monitoring ExtensionRNS
28.11.2019 07:00 FDA has approved Faron's Clevegen INDRNS
27.11.2019 16:00 Faron´s financial calendar for 2020RNS
21.11.2019 14:00 Holdings in CompanyRNS
21.11.2019 09:00 Price Monitoring ExtensionRNS
21.11.2019 07:15 Application to Nasdaq First North Growth MarketRNS
19.11.2019 11:05 Second Price Monitoring ExtnRNS
19.11.2019 11:00 Price Monitoring ExtensionRNS
15.11.2019 11:06 Second Price Monitoring ExtnRNS
15.11.2019 11:00 Price Monitoring ExtensionRNS
12.11.2019 15:45 Registration of SharesRNS
08.11.2019 07:00 Results of Placing and Issue PriceRNS
07.11.2019 16:51 Proposed Placing and Financial Adviser AppointmentRNS
05.11.2019 16:40 Second Price Monitoring ExtnRNS
05.11.2019 16:36 Price Monitoring ExtensionRNS
05.11.2019 14:05 Second Price Monitoring ExtnRNS
05.11.2019 14:00 Price Monitoring ExtensionRNS
05.11.2019 11:05 Second Price Monitoring ExtnRNS
05.11.2019 11:00 Price Monitoring ExtensionRNS
05.11.2019 09:05 Second Price Monitoring ExtnRNS
05.11.2019 09:00 Price Monitoring ExtensionRNS
04.11.2019 16:35 Price Monitoring ExtensionRNS
04.11.2019 14:05 Second Price Monitoring ExtnRNS
04.11.2019 14:00 Price Monitoring ExtensionRNS
Showing 1 to 100 of 1,000